Last reviewed · How we verify

Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects

NCT05381870 PHASE1 UNKNOWN

The fasting bioequivalence test adopts the experimental design of single center, single oral administration, random, open, two sequence, two cycle crossover and self-control.

Details

Lead sponsorThe Affiliated Hospital of Qingdao University
PhasePHASE1
StatusUNKNOWN
Enrolment48
Start dateThu May 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionFri Dec 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions